Antiplatelet Therapy for Long-Term Management of Patients with Mechanical Aortic Prostheses.

Raúl Garcia RinaldiJuan Rodriguez-AcostaDavid BermúdezÁngel GaleraShaira QuinonesJeanette Quinones

Published in: The Journal of heart valve disease (2019)

Platelet-mediated thromboembolism following MAP installation can be treated with antiplatelet agents. The 16-year results of the present study suggested that antiplatelet agents can reduce thromboembolic events in patients with MAP. Strokes can be prevented in patients with MAP if treated with the correct antiplatelet agent, if the patient responds to the agent employed and is strictly compliant.

Keyphrases

antiplatelet therapy
acute coronary syndrome
percutaneous coronary intervention
high density
case report
left ventricular
atrial fibrillation
pulmonary artery
newly diagnosed
coronary artery